Zhejiang AngLiKang Pharmaceutical CO.,LTD. (002940.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap6.74B
Enterprise Value6.79B
P/E Ratio41.23
PEG Ratio0.47
Price/Sales Ratio3.65
Price/Book Ratio3.14
Enterprise/Revenue3.76
Enterprise/EBITDA23.57

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.09
Operating Margin0.12
AD

Management Effectiveness

Return On Assets0.04
Return On Equity0.08

Income Statement

Revenue1.42B
Revenue/Share7.24
Gross Profit526.55M
EBITDA271.87M
Net Income125.44M
Diluted EPS0.62

Balance Sheet

Total Cash891.09M
Total Cash/Share4.54
Total Debt762.23M
Total Debt/Equity0.46
Current Ratio1.84
Book Value Per Share9.65

Price History

52-Week Change-47.8
52-Week High58.93
52-Week Low23.11
Moving Average 50 Days26.82
Moving Average 200 Days32.54

Statistics

Average Volume15.45M
Shares Outstanding196.11M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.25
Trailing Annual Dividend Yield0.95
Payout Ratio0.44
Last Split Factor29:20
Last Split DateMay 19, 2023
AD